Compare LAB & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAB | AVNS |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.4M | 521.7M |
| IPO Year | 2011 | N/A |
| Metric | LAB | AVNS |
|---|---|---|
| Price | $1.48 | $13.19 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.35 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 548.2K |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $169,737,000.00 | ★ $699,900,000.00 |
| Revenue This Year | N/A | $3.07 |
| Revenue Next Year | N/A | $2.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 79.77 | 2.70 |
| 52 Week Low | $0.92 | $9.30 |
| 52 Week High | $1.72 | $17.69 |
| Indicator | LAB | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 48.94 | 69.54 |
| Support Level | $1.50 | $12.87 |
| Resistance Level | $1.67 | $13.28 |
| Average True Range (ATR) | 0.10 | 0.45 |
| MACD | -0.00 | 0.13 |
| Stochastic Oscillator | 54.66 | 92.75 |
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.